What is empagliflozin ?

Empagliflozin is a medication used to treat type 2 diabetes mellitus (T2DM), heart failure, and chronic kidney disease (CKD). It belongs to a class of drugs called SGLT2 inhibitors (sodium-glucose co-transporter-2 inhibitors), which help lower blood sugar levels by causing the kidneys to excrete excess glucose through urine.

Uses of Empagliflozin:

  1. Type 2 Diabetes Mellitus (T2DM):

    • Lowers blood sugar by reducing glucose reabsorption in the kidneys.
    • Helps with weight loss and reduces blood pressure.
    • Often prescribed alongside metformin or other diabetes medications.
  2. Heart Failure (HF):

    • Improves heart function by reducing fluid overload.
    • Lowers the risk of hospitalization for heart failure.
  3. Chronic Kidney Disease (CKD):

    • Protects kidney function by reducing the progression of kidney disease.
    • Lowers the risk of cardiovascular events in CKD patients.

Brand Names:

  • Jardiance® (common brand name)
  • Synjardy® (combination with metformin)
  • Glyxambi® (combination with linagliptin)

Common Side Effects:

  • Increased urination
  • Dehydration and low blood pressure
  • Urinary tract infections (UTIs)
  • Genital infections (e.g., yeast infections)
  • Risk of diabetic ketoacidosis (DKA), though rare

Who Should Avoid Empagliflozin?

  • Patients with type 1 diabetes (increases the risk of DKA)
  • Severe kidney disease or dialysis patients
  • Those prone to frequent urinary or genital infections

Comments

Popular posts from this blog

Understanding the Sources of N-Nitroso Contamination in Drug Manufacturing

Abemaciclib D7: Elevating Pharmaceutical Research and Analytical Excellence

Palmityl Trimethylsilyl Fumarate – High-Purity Impurity Standard for Analytical Research